Search for Clinical Trial Results

Sponsored By

Lung Adenocarcinoma - 25 Studies Found

Status Study
Active, not recruiting Study Name: Molecular Analysis of 150 Lung Adenocarcinoma
Condition: Lung Adenocarcinoma
Date: 2016-07-20
Interventions: Genetic: Sequencing Tumour samples are coming from routine histopathological procedure. They are used wi
Active, not recruiting Study Name: Expression of AMP-activated Protein Kinase (AMPK) Protein in Lung Adenocarcinoma
Condition: Lung Adenocarcinoma
Date: 2010-11-24
Active, not recruiting Study Name: Study of Early-stage Lung Adenocarcinoma for Early Detection and Effective Treatment Strategy
Condition: Lung Adenocarcinoma
Date: 2011-11-28
Interventions: Other: CT, PET, copy number alteration Duel-energy CT, PET, copy number alteration
Not yet recruiting Study Name: Clinical Trial of Erlotinib and Pemetrexed for Maintenance Treatment in Lung Adenocarcinoma
Condition: Lung Adenocarcinoma
Date: 2015-03-22
Interventions: Drug: Erlotinib, Pemetrexed followed classical chemotherapy for 4 cycles, use Erlotinib orally for the m
Recruiting Study Name: Pemetrexed and Platinum Use in the Neoadjuvant Setting for Resectable Stage II and IIIA Lung Adenocarcinoma
Condition: Lung Adenocarcinoma
Date: 2014-12-16
Interventions:
  • Drug: Pemetrexed Two cycles of
Completed Study Name: Cetuximab in Patients With Lung Adenocarcinoma Receiving Erlotinib That Have Developed "Acquired Resistance" to Erlotinib
Condition: Lung Adenocarcinoma
Date: 2008-07-15
Interventions: Drug: erlotinib with cetuximab The phase I portion will accrue as many as 3 cohorts of 3-6 patients; rec
Recruiting Study Name: A Study Examining Maintenance Avastin Monotherapy in Patients With Advanced Lung Adenocarcinoma
Condition: Lung Adenocarcinoma
Date: 2014-03-19
Recruiting Study Name: Chemotherapy Combined Autologous Cytokine-induced Killer Cells in Naive Stage IV EGFR-wild Type Lung Adenocarcinoma
Condition: Lung Adenocarcinoma
Date: 2015-11-25
Interventions:
  • Biological: CIK platinum combi
Not yet recruiting Study Name: Chemotherapy Plus Gefitinib for Advanced Lung Adenocarcinoma and Sensitive EGFR Mutations: a Randomized Controlled Trial
Condition: Lung Adenocarcinoma
Date: 2016-10-15
Interventions:
  • Drug: Pemetrexed plus carboplatin combined with gefitinib

Not yet recruiting Study Name: Apatinib Plus Docetaxel as 2nd Line Treatment in Patients With Advanced Lung Adenocarcinoma Harboring Wild-type EGFR
Condition: Lung Adenocarcinoma
Date: 2016-02-03
Interventions:
  • Drug: Apatinib (250 mg/d) + Docetaxel (60 mg/m2)
Next >>>